{"DataElement":{"publicId":"5229060","version":"1","preferredName":"Kidney Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"Stage group determined from information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for kidney carcinoma.","longName":"5228912v1.0:5229045v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"5228912","version":"1","preferredName":"Kidney Carcinoma Stage Grouping","preferredDefinition":"A carcinoma arising from the epithelium of the renal parenchyma or the renal pelvis.  The majority are renal cell carcinomas.  Kidney carcinomas usually affect middle aged and elderly adults.  Hematuria, abdominal pain, and a palpable mass are common symptoms._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"3201550v1.0:2230143v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3201550","version":"1","preferredName":"Renal Carcinoma","preferredDefinition":"A carcinoma arising from the epithelium of the renal parenchyma (renal cell carcinoma) or the renal pelvis (renal pelvis carcinoma).  The vast majority of renal cell carcinomas are adenocarcinomas.  The vast majority of renal pelvis carcinomas are transit","longName":"C9384","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Carcinoma","conceptCode":"C9384","definition":"A carcinoma arising from the epithelium of the renal parenchyma or the renal pelvis.  The majority are renal cell carcinomas.  Kidney carcinomas usually affect middle aged and elderly adults.  Hematuria, abdominal pain, and a palpable mass are common symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E241B3C-89F4-11DA-E040-BB89AD437FA3","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-10","modifiedBy":"ONEDATA","dateModified":"2011-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"30EF198C-0130-7F43-E050-BB89AD43421D","latestVersionIndicator":"Yes","beginDate":"2016-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-20","modifiedBy":"HARTLEYG","dateModified":"2016-07-26","changeDescription":"Created for BBRB project by request of G.Deen. mc 4/20/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5229045","version":"1","preferredName":"Renal Cell Carcinoma by AJCC v7 Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the staging of renal cell carcinoma according to the American Joint Committee on Cancer, 7th edition._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"5229045v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Stage IV Renal Cell Cancer","ValueMeaning":{"publicId":"5229047","version":"1","preferredName":"Stage IV Renal Cell Cancer","longName":"5229047","preferredDefinition":"Stage IV includes: (T4, Any N, M0); (Any T, Any N, M1). T4: Tumor invades beyond Gerota's fascia (including contiguous extension into the ipsilateral adrenal gland).  M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Renal Cell Cancer AJCC v7","conceptCode":"C89303","definition":"Stage IV includes: (T4, Any N, M0); (Any T, Any N, M1). T4: Tumor invades beyond Gerota's fascia (including contiguous extension into the ipsilateral adrenal gland).  M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FEA185-196E-AE99-E050-BB89AD433FD1","latestVersionIndicator":"Yes","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30FEA185-1987-AE99-E050-BB89AD433FD1","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"ONEDATA","dateModified":"2016-04-21","deletedIndicator":"No"},{"value":"III","valueDescription":"Stage III Renal Cell Cancer","ValueMeaning":{"publicId":"5229049","version":"1","preferredName":"Stage III Renal Cell Cancer","longName":"5229049","preferredDefinition":"Stage III includes: (T1 or T2, N1, M0); (T3, N0 or N1, M0).  T1: Lesions have been divided into T1a and T1b.  T1a is defined as tumor 4 cm or less in greatest dimension, limited to the kidney.  T1b is defined as tumor greater than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney. T2: Lesions have been divided into T2a and T2b.  T2a is defined as tumor more than 7 cm but less than or equal to 10 cm in greatest dimension, limited to the kidney.  T2b is defined as tumor greater than 10 cm, limited to the kidney.  T3: Tumor extends into major veins or perinephric tissues, but not into the ipsilateral adrenal gland and not beyond Gerota's fascia. Lesions have been divided into T3a, T3b, and T3c. T3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) branches, or tumor invades perirenal and/or renal sinus fat but not beyond Gerota's fascia.  T3b: Tumor grossly extends into the vena cava below the diaphragm. T3c: Tumor grossly extends into the vena cava above the diaphragm or invades the wall of the vena cava.  N0: No regional lymph node metastasis.  N1: Metastasis in regional lymph node(s). M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Renal Cell Cancer AJCC v7","conceptCode":"C89302","definition":"Stage III includes: (T1 or T2, N1, M0); (T3, N0 or N1, M0).  T1: Lesions have been divided into T1a and T1b.  T1a is defined as tumor 4 cm or less in greatest dimension, limited to the kidney.  T1b is defined as tumor greater than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney. T2: Lesions have been divided into T2a and T2b.  T2a is defined as tumor more than 7 cm but less than or equal to 10 cm in greatest dimension, limited to the kidney.  T2b is defined as tumor greater than 10 cm, limited to the kidney.  T3: Tumor extends into major veins or perinephric tissues, but not into the ipsilateral adrenal gland and not beyond Gerota's fascia. Lesions have been divided into T3a, T3b, and T3c. T3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) branches, or tumor invades perirenal and/or renal sinus fat but not beyond Gerota's fascia.  T3b: Tumor grossly extends into the vena cava below the diaphragm. T3c: Tumor grossly extends into the vena cava above the diaphragm or invades the wall of the vena cava.  N0: No regional lymph node metastasis.  N1: Metastasis in regional lymph node(s). M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FEA185-1994-AE99-E050-BB89AD433FD1","latestVersionIndicator":"Yes","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30FEA185-19AD-AE99-E050-BB89AD433FD1","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"ONEDATA","dateModified":"2016-04-21","deletedIndicator":"No"},{"value":"II","valueDescription":"Stage II Renal Cell Cancer","ValueMeaning":{"publicId":"5229051","version":"1","preferredName":"Stage II Renal Cell Cancer","longName":"5229051","preferredDefinition":"Stage II includes: T2, N0, M0.  T2: Lesions have been divided into T2a and T2b.  T2a is defined as tumor more than 7 cm but less than or equal to 10 cm in greatest dimension, limited to the kidney.  T2b is defined as tumor greater than 10 cm, limited to the kidney.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Renal Cell Cancer AJCC v7","conceptCode":"C89301","definition":"Stage II includes: T2, N0, M0.  T2: Lesions have been divided into T2a and T2b.  T2a is defined as tumor more than 7 cm but less than or equal to 10 cm in greatest dimension, limited to the kidney.  T2b is defined as tumor greater than 10 cm, limited to the kidney.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FEA185-19BA-AE99-E050-BB89AD433FD1","latestVersionIndicator":"Yes","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30FEA185-19D3-AE99-E050-BB89AD433FD1","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"ONEDATA","dateModified":"2016-04-21","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I Renal Cell Cancer","ValueMeaning":{"publicId":"5229053","version":"1","preferredName":"Stage I Renal Cell Cancer","longName":"5229053","preferredDefinition":"Stage I includes: T1, N0, M0.  T1: Lesions have been divided into T1a and T1b.  T1a is defined as tumor 4 cm or less in greatest dimension, limited to the kidney.  T1b is defined as tumor greater than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  (AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Renal Cell Cancer AJCC v6 and v7","conceptCode":"C7823","definition":"Stage I includes: T1, N0, M0.  T1: Lesions have been divided into T1a and T1b.  T1a is defined as tumor 4 cm or less in greatest dimension, limited to the kidney.  T1b is defined as tumor greater than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  (AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FEA185-19E0-AE99-E050-BB89AD433FD1","latestVersionIndicator":"Yes","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30FEA185-19F9-AE99-E050-BB89AD433FD1","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"ONEDATA","dateModified":"2016-04-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5229044","version":"1","preferredName":"Renal Cell Carcinoma by AJCC v7 Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the staging of renal cell carcinoma according to the American Joint Committee on Cancer, 7th edition.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C91201:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Cell Cancer by AJCC v7 Stage","conceptCode":"C91201","definition":"A term that refers to the staging of renal cell cancer according to the American Joint Committee on Cancer, 7th edition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FEA185-1942-AE99-E050-BB89AD433FD1","latestVersionIndicator":"Yes","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"ONEDATA","dateModified":"2016-04-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FEA185-1953-AE99-E050-BB89AD433FD1","latestVersionIndicator":"Yes","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"HARTLEYG","dateModified":"2016-07-26","changeDescription":"Created for BBRB as requested by G.Deen. mc 4/21/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"5228272","version":"1","longName":"Kidney","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736422","version":"1","longName":"Kidney Clinical Data Entry","context":"BBRB"},{"publicId":"6736423","version":"1","longName":"Kidney Local Path Review","context":"BBRB"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000432","version":"1","longName":"Kidney","context":"NCI Standards"}]}],"AlternateNames":[{"name":"BBRB","type":"USED_BY","context":"BBRB"}],"ReferenceDocuments":[{"name":"Disease Stage","type":"Preferred Question Text","description":"Disease Stage","url":null,"context":"NCI Standards"},{"name":"BPV_GTEx","type":"BBRB Text","description":"Clinical tumor stage group (AJCC 7th Edition)","url":null,"context":"BBRB"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"30FEE52A-EC4B-91CB-E050-BB89AD4333ED","latestVersionIndicator":"Yes","beginDate":"2016-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-04-21","modifiedBy":"TAYLORT","dateModified":"2017-04-19","changeDescription":"Created for BBRB as requested by G. Deen. mc 4/21/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}